Adipose Inflammation and Diabetes (FAB)
ConditionObese
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorGöteborg University
About this trial
The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.
Eligibility criteria
Qualifiers
BMI 30-40 kg/m2
Ptos (i.e. excess skin) > 3 cm
Patient underwent gastric bypass surgery >2 years ago
Patient has had a stable weight ≥6 months at the time of operation
Disqualifiers
Patients who do not understand spoken and written Swedish
American Society of Anesthesiologists (ASA) classification ≥ 3
Neurological, orthopedic or rheumatologic injury or illness affecting physical ability
Preoperatively known hernia requiring surgical operation
Trial design
Treatments tested in this trial
- Not listed
Trial groups
18 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov